Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - estriol 0.5mg;   - pessary - 0.5 mg - active: estriol 0.5mg   excipient: hard fat - atrophy of the lower urogenital tract related to oestrogen deficiency, notably · for the treatment of vaginal complaints such as dyspareunia, dryness and itching · for the prevention of recurrent infections of the vagina and the lower urinary tract · in the management of micturition complaints (such as frequency and dysuria) and mild urinary incontinence. pre- and postoperative therapy in postmenopausal women undergoing vaginal surgery. a diagnostic aid in case of a doubtful atrophic cervical smear.

Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - estriol 2mg;   - tablet - 2 mg - active: estriol 2mg   excipient: colloidal silicon dioxide lactose monohydrate magnesium stearate potato starch povidone - atrophy of the lower urogenital tract related to oestrogen deficiency, notably · for the treatment of vaginal complaints such as dyspareunia, dryness and itching · for the prevention of recurrent infections of the vagina and the lower urinary tract · in the management of micturition complaints (such as frequency and dysuria) and mild urinary incontinence. pre- and postoperative therapy in postmenopausal women undergoing vaginal surgery. climacteric complaints such as hot flushes and night sweating. a diagnostic aid in case of a doubtful atropic cervical smear. infertility due to cervical hostility.

Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - estriol 0.1%{relative};   - vaginal cream - 0.1 % - active: estriol 0.1%{relative}   excipient: cetyl alcohol chlorhexidine hydrochloride glycerol lactic acid octyldodecanol polysorbate 60 purified water sodium hydroxide sorbitan stearate spermaceti stearyl alcohol - atrophy of the lower urogenital tract related to oestrogen deficiency, notably: · for the treatment of vaginal complaints such as dyspareunia, dryness and itching. · for the prevention of recurrent infections of the vagina and lower urinary tract. · in the management of micturition complaints (such as frequency and dysuria) and mild urinary incontinence. pre- and post-operative therapy in postmenopausal women undergoing vaginal surgery. a diagnostic aid in case of a doubtful atrophic cervical smear.

Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - sildenafil citrate 140.45mg equivalent to 100 mg sildenafil;   - film coated tablet - 100 mg - active: sildenafil citrate 140.45mg equivalent to 100 mg sildenafil   excipient: calcium hydrogen phosphate croscarmellose sodium magnesium stearate microcrystalline cellulose opadry blue oy-ls-20921 opadry clear ys-2-19114-a purified water - viagra is indicated for the treatment of erectile dysfunction in adult males

Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - sildenafil citrate 35.112mg equivalent to 25 mg sildenafil - film coated tablet - 25 mg - active: sildenafil citrate 35.112mg equivalent to 25 mg sildenafil excipient: calcium hydrogen phosphate croscarmellose sodium magnesium stearate microcrystalline cellulose opadry blue oy-ls-20921 opadry clear ys-2-19114-a purified water - viagra is indicated for the treatment of erectile dysfunction in adult males

Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - sildenafil citrate 70.225mg equivalent to 50 mg sildenafil;   - film coated tablet - 50 mg - active: sildenafil citrate 70.225mg equivalent to 50 mg sildenafil   excipient: calcium hydrogen phosphate croscarmellose sodium magnesium stearate microcrystalline cellulose opadry blue oy-ls-20921 opadry clear ys-2-19114-a purified water - viagra is indicated for the treatment of erectile dysfunction in adult males

Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - flucloxacillin sodium monohydrate 1048mg equivalent to flucloxacillin 1000 mg - powder for injection - 1 g - active: flucloxacillin sodium monohydrate 1048mg equivalent to flucloxacillin 1000 mg - flucil is indicated for the treatment of skin and soft tissue infections caused by susceptible organisms and infections due to penicillinase producing staphylococci and for mixed streptococcal and staphylococcal infections where the staphylococci are resistant to penicillin. for example, infections of the joints, respiratory tract and urinary tract, otitis media, endocarditis, septicaemia, and meningitis. flucil is also used in the prophylaxis of staphylococcal infections during major surgical procedures, particularly in cardiothoracic or orthopaedic surgery.

Новая Зеландия - английский - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - flucloxacillin sodium monohydrate 524mg equivalent to flucloxacillin 500 mg - powder for injection - 500 mg - active: flucloxacillin sodium monohydrate 524mg equivalent to flucloxacillin 500 mg - flucil is indicated for the treatment of skin and soft tissue infections caused by susceptible organisms and infections due to penicillinase producing staphylococci and for mixed streptococcal and staphylococcal infections where the staphylococci are resistant to penicillin. for example, infections of the joints, respiratory tract and urinary tract, otitis media, endocarditis, septicaemia, and meningitis. flucil is also used in the prophylaxis of staphylococcal infections during major surgical procedures, particularly in cardiothoracic or orthopaedic surgery.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - atorvastatin calcium trihydrate, quantity: 86.8 mg (equivalent: atorvastatin, qty 80 mg) - tablet, film coated - excipient ingredients: magnesium stearate; polysorbate 80; croscarmellose sodium; hyprolose; lactose monohydrate; calcium carbonate; microcrystalline cellulose; purified water; methyl hydroxybenzoate; dimeticone 1000; sorbitan monostearate; polysorbate 60; guar gum; bronopol; titanium dioxide; macrogol 8000; hypromellose; purified talc - lipitor is indicated as an adjunct to diet for the treatment of patients with hypercholesterolaemia. prior to initiating therapy with atorvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, and alcoholism) should be identified and treated. lipitor is indicated in hypertensive patients with multiple risk factors for coronary heart disease (chd) which may include diabetes, history of stroke or other cerebrovascular disease, peripheral vascular disease or existing asymptomatic chd (see clinical trials, prevention of cardiovascular disease) to reduce the risk of non-fatal myocardial infarction and non-fatal stroke. these effects do not replace the need to independently control known causes of cardiovascular mortality and morbidity such as hypertension, diabetes and smoking.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - atorvastatin calcium trihydrate, quantity: 43.4 mg (equivalent: atorvastatin, qty 40 mg) - tablet, film coated - excipient ingredients: polysorbate 80; magnesium stearate; calcium carbonate; croscarmellose sodium; lactose monohydrate; microcrystalline cellulose; hyprolose; purified water; methyl hydroxybenzoate; dimeticone 1000; sorbitan monostearate; polysorbate 60; guar gum; bronopol; titanium dioxide; macrogol 8000; hypromellose; purified talc - lipitor is indicated as an adjunct to diet for the treatment of patients with hypercholesterolaemia. prior to initiating therapy with atorvastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, and alcoholism) should be identified and treated. lipitor is indicated in hypertensive patients with multiple risk factors for coronary heart disease (chd) which may include diabetes, history of stroke or other cerebrovascular disease, peripheral vascular disease or existing asymptomatic chd (see clinical trials, prevention of cardiovascular disease) to reduce the risk of non-fatal myocardial infarction and non-fatal stroke. these effects do not replace the need to independently control known causes of cardiovascular mortality and morbidity such as hypertension, diabetes and smoking.